Alibaba
BABA
Tesla
TSLA
Apple
AAPL
4
Intel
INTC
5
Netflix
NFLX
US Stock MarketDetailed Quotes
APVO Aptevo Therapeutics
- 1.235
- -0.305-19.81%
Trading Mar 27 15:40 ET
1.80MMarket Cap-0.01P/E (TTM)
1.540High1.230Low159.84KVolume1.530Open1.540Pre Close209.18KTurnover10.96%Turnover RatioLossP/E (Static)1.46MShares180.19052wk High0.38P/B1.80MFloat Cap1.23052wk Low--Dividend TTM1.46MShs Float144729.200Historical High--Div YieldTTM20.12%Amplitude1.230Historical Low1.308Avg Price1Lot Size
Aptevo Therapeutics Key Stats
EPS
According to the latest financial report of Aptevo Therapeutics, the latest earnings per share (TTM) for the company is -4.33. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Aptevo Therapeutics's free cash flow? The latest report shows it as -5.76M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Aptevo Therapeutics shows that the company's current ratio is 1.72, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Aptevo Therapeutics, the quick ratio is 1.40, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Aptevo Therapeutics? The latest ROE figure is -137.59%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Aptevo Therapeutics, the total asset return on investment (ROA) is -41.07%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Aptevo Therapeutics's latest financial report to see how their gross margin is doing - currently at 29.69%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Aptevo Therapeutics, the net profit margin is -247.17%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025